IL244702B - Novel histories of 3-(h1-pyrazol-4-yl)-h1-pyrrolo[3,2-c]pyridine as nick inhibitors - Google Patents

Novel histories of 3-(h1-pyrazol-4-yl)-h1-pyrrolo[3,2-c]pyridine as nick inhibitors

Info

Publication number
IL244702B
IL244702B IL244702A IL24470216A IL244702B IL 244702 B IL244702 B IL 244702B IL 244702 A IL244702 A IL 244702A IL 24470216 A IL24470216 A IL 24470216A IL 244702 B IL244702 B IL 244702B
Authority
IL
Israel
Prior art keywords
pyrrolo
pyrazol
new
pyridine derivatives
nik inhibitors
Prior art date
Application number
IL244702A
Other languages
English (en)
Hebrew (he)
Other versions
IL244702A0 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL244702A0 publication Critical patent/IL244702A0/en
Publication of IL244702B publication Critical patent/IL244702B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epidemiology (AREA)
IL244702A 2013-09-26 2016-03-22 Novel histories of 3-(h1-pyrazol-4-yl)-h1-pyrrolo[3,2-c]pyridine as nick inhibitors IL244702B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13186148 2013-09-26
EP14176125 2014-07-08
PCT/EP2014/070489 WO2015044269A1 (en) 2013-09-26 2014-09-25 NEW 3-(1H-PYRAZOL-4-YL)-1H-PYRROLO[2,3-c]PYRIDINE DERIVATIVES AS NIK INHIBITORS

Publications (2)

Publication Number Publication Date
IL244702A0 IL244702A0 (en) 2016-04-21
IL244702B true IL244702B (en) 2019-07-31

Family

ID=51626028

Family Applications (1)

Application Number Title Priority Date Filing Date
IL244702A IL244702B (en) 2013-09-26 2016-03-22 Novel histories of 3-(h1-pyrazol-4-yl)-h1-pyrrolo[3,2-c]pyridine as nick inhibitors

Country Status (14)

Country Link
US (1) US9981963B2 (https=)
EP (1) EP3049412B1 (https=)
JP (1) JP6404332B2 (https=)
KR (1) KR102317335B1 (https=)
CN (1) CN105579452B (https=)
AU (1) AU2014327235B2 (https=)
BR (1) BR112016006232B1 (https=)
CA (1) CA2922633C (https=)
EA (1) EA028101B1 (https=)
ES (1) ES2643070T3 (https=)
IL (1) IL244702B (https=)
MX (1) MX365739B (https=)
TW (1) TWI627173B (https=)
WO (1) WO2015044269A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI663166B (zh) 2013-04-24 2019-06-21 健生藥品公司 新化合物
TWI704146B (zh) 2013-09-26 2020-09-11 比利時商健生藥品公司 用作NIK抑制劑之新的1-(4-嘧啶基)-1H-吡唑並[3,2-c]吡啶衍生物
TWI627173B (zh) 2013-09-26 2018-06-21 比利時商健生藥品公司 作為NIK抑制劑的新穎3-(1H-吡唑-4-基)-1H-吡咯并[2,3-c]吡啶衍生物
AU2015334917B2 (en) 2014-10-23 2019-08-29 Janssen Pharmaceutica Nv New compounds as NIK inhibitors
JP6616412B2 (ja) 2014-10-23 2019-12-04 ヤンセン ファーマシューティカ エヌ.ベー. Nik阻害剤としての新規のピラゾロピリミジン誘導体
BR112017008039B1 (pt) 2014-10-23 2023-04-11 Janssen Pharmaceutica N.V. Derivados de pirazol como inibidores de nik, seu uso no tratamento ou prevenção de câncer e composição farmacêutica que os compreende
MX371151B (es) 2014-10-23 2020-01-20 Janssen Pharmaceutica Nv NUEVOS DERIVADOS DE TIENOPIRIMIDINA EN CALIDAD DE INHIBIDORES DE LA CINASA INDUCTORA DE NF-kB (NIK).
JP7011596B2 (ja) * 2015-12-02 2022-02-10 アストライア セラピューティクス, エルエルシー ピペリジニルノシセプチン受容体化合物
US10112924B2 (en) 2015-12-02 2018-10-30 Astraea Therapeutics, Inc. Piperdinyl nociceptin receptor compounds
EP3405464B1 (en) 2016-01-22 2019-12-04 Janssen Pharmaceutica NV New 6-membered heteroaromatic substituted cyanoindoline derivatives as nik inhibitors
ES2775449T3 (es) 2016-01-22 2020-07-27 Janssen Pharmaceutica Nv Nuevos derivados de cianoindolina sustituida como inhibidores de nik
WO2018002217A1 (en) 2016-06-30 2018-01-04 Janssen Pharmaceutica Nv Heteroaromatic derivatives as nik inhibitors
ES2837157T3 (es) 2016-06-30 2021-06-29 Janssen Pharmaceutica Nv Derivados de cianoindolina como inhibidores de NIK
WO2020162638A1 (ja) * 2019-02-08 2020-08-13 学校法人近畿大学 悪性腫瘍疾患の改善用組成物
CN114222737B (zh) 2019-05-31 2024-07-26 詹森药业有限公司 NF-κB诱导激酶的小分子抑制剂
CN110156766A (zh) * 2019-06-04 2019-08-23 南京工业大学 一种银催化的氘代五元芳香杂环化合物的制备方法
WO2022138735A1 (ja) 2020-12-22 2022-06-30 学校法人近畿大学 悪性腫瘍疾患の改善用医薬組成物
TW202402269A (zh) * 2022-05-26 2024-01-16 大陸商迪哲(江蘇)醫藥股份有限公司 ROCK(Rho相關激酶)抑制劑及其用途
WO2024029528A1 (ja) 2022-08-02 2024-02-08 学校法人近畿大学 アレルギー性疾患の改善用医薬組成物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3990061B2 (ja) * 1998-01-05 2007-10-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 プリン誘導体および糖尿病の予防・治療剤としてのアデノシンa2受容体拮抗剤
DE19948417A1 (de) * 1999-10-07 2001-04-19 Morphochem Ag Imidazol-Derivate und ihre Verwendung als Arzneimittel
WO2005103003A2 (en) 2004-04-26 2005-11-03 Pfizer Inc. Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors
TW200736260A (en) 2005-11-10 2007-10-01 Smithkline Beecham Corp Inhibitors of Akt activity
DE102008005493A1 (de) 2008-01-22 2009-07-23 Merck Patent Gmbh 4-(Pyrrolo[2,3-c] pyridine-3-yl)-pyrimidin-2-yl-amin-derivate
AU2009263037B2 (en) 2008-06-26 2011-10-06 Amgen Inc. Alkynyl alcohols as kinase inhibitors
CN102143746A (zh) 2008-07-03 2011-08-03 埃克塞利希斯股份有限公司 Cdk 调节剂
WO2010042337A1 (en) * 2008-10-07 2010-04-15 Merck Sharp & Dohme Corp. Novel 6-azaindole aminopyrimidine derivatives having nik inhibitory activity
CN101723936B (zh) 2008-10-27 2014-01-15 上海睿星基因技术有限公司 激酶抑制剂及其在药学中的用途
WO2011050245A1 (en) 2009-10-23 2011-04-28 Yangbo Feng Bicyclic heteroaryls as kinase inhibitors
MX2013010513A (es) * 2011-03-16 2013-10-07 Hoffmann La Roche Compuestos de alcohol 6,5-heterociclil-propargilico y usos de los mismos.
TWI663166B (zh) * 2013-04-24 2019-06-21 健生藥品公司 新化合物
TWI704146B (zh) * 2013-09-26 2020-09-11 比利時商健生藥品公司 用作NIK抑制劑之新的1-(4-嘧啶基)-1H-吡唑並[3,2-c]吡啶衍生物
TWI627173B (zh) 2013-09-26 2018-06-21 比利時商健生藥品公司 作為NIK抑制劑的新穎3-(1H-吡唑-4-基)-1H-吡咯并[2,3-c]吡啶衍生物
BR112017008039B1 (pt) 2014-10-23 2023-04-11 Janssen Pharmaceutica N.V. Derivados de pirazol como inibidores de nik, seu uso no tratamento ou prevenção de câncer e composição farmacêutica que os compreende
AU2015334917B2 (en) 2014-10-23 2019-08-29 Janssen Pharmaceutica Nv New compounds as NIK inhibitors
MX371151B (es) 2014-10-23 2020-01-20 Janssen Pharmaceutica Nv NUEVOS DERIVADOS DE TIENOPIRIMIDINA EN CALIDAD DE INHIBIDORES DE LA CINASA INDUCTORA DE NF-kB (NIK).
JP6616412B2 (ja) 2014-10-23 2019-12-04 ヤンセン ファーマシューティカ エヌ.ベー. Nik阻害剤としての新規のピラゾロピリミジン誘導体

Also Published As

Publication number Publication date
US9981963B2 (en) 2018-05-29
EA201690657A1 (ru) 2016-08-31
JP6404332B2 (ja) 2018-10-10
EP3049412B1 (en) 2017-07-12
CA2922633A1 (en) 2015-04-02
AU2014327235B2 (en) 2018-02-08
IL244702A0 (en) 2016-04-21
BR112016006232A2 (pt) 2017-08-01
KR20160060054A (ko) 2016-05-27
EP3049412A1 (en) 2016-08-03
MX2016003863A (es) 2016-08-04
CA2922633C (en) 2022-07-26
US20160229851A1 (en) 2016-08-11
TWI627173B (zh) 2018-06-21
MX365739B (es) 2019-06-12
EA028101B1 (ru) 2017-10-31
BR112016006232B1 (pt) 2022-11-29
JP2016531858A (ja) 2016-10-13
KR102317335B1 (ko) 2021-10-26
CN105579452B (zh) 2018-01-23
ES2643070T3 (es) 2017-11-21
TW201602103A (zh) 2016-01-16
CN105579452A (zh) 2016-05-11
WO2015044269A1 (en) 2015-04-02
AU2014327235A1 (en) 2016-03-17

Similar Documents

Publication Publication Date Title
IL244702A0 (en) Novel histories of 3-(h1-pyrazol-4-yl)-h1-pyrrolo[3,2-c]pyridine as nik inhibitors
IL252065B (en) Thiano[2,3-c]pyrrol-4-ion derivatives as erk inhibitors
IL244706A0 (en) Novel histories of 1-(4-pyrimidinyl)-1h-pyrrolo[2,3-c]pyridine as nik inhibitors
ZA201705802B (en) 4h-pyrrolo[3,2-c]pyridin-4-one derivatives
EP2968311A4 (en) OXAZOLO [5,4-C] CHINOLIN-2-ON COMPOUNDS AS BROMODOMENA INHIBITORS
ZA201405070B (en) 1h-pyrrolo[2,3-b] pyridine derivatives and their use as kinase inhibitors
IL242170B (en) Derivatives of 3-(2-aminopyrimidine-4yl)-5-(3-hydroxypropynyl)-h1-pyrrolo[2,3-pyridine as nickel inhibitors for cancer treatment
SI2812337T1 (sl) Furo (3,2-b) in tieno (3,2-b) piridinski derivati kot zaviralci tbk1 in ikk
LT3074400T (lt) Oktahidro-ciklobuta [1,2-c;3,4-c`]dipirolo dariniai kaip autotaksino inhibitoriai
IL244609A0 (en) History of 4-azaindole
SG11201408816QA (en) 3-(PYRAZOLYL)-1H-PYRROLO[2,3-b]PYRIDINE DERIVATIVES AS KINASE INHIBITORS
IL241363A0 (en) History of pyridine-4-yl
EP2970278A4 (en) Pyrrolo [2,3] PYRIDINE KINASE INHIBITORS CDK9-
IL232717B (en) 3-cyanoaryl-h1-pyrrolo[b-3,2]pyridine derivatives
HUE050104T2 (hu) 3,5N-trihidroxi-alkánamid és származékok: eljárás ennek elõállítására és ennek felhasználása
SG11201500883YA (en) 5-(1H-PYRAZOL-4-YL)-1H-PYRROLO[2,3-b]PYRIDINE DERIVATIVES AS KINASE INHIBITORS
HUE038944T2 (hu) Tiokromeno[2,3-c]kinolin-12-on származékok és topoizomeráz inhibitorként való alkalmazásuk
GB201300892D0 (en) Novel isothiazolo[4,3-b]pyridines
ZA201504041B (en) (thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity h1 inverse agonists/5-ht2a antagonists
GB201211756D0 (en) Novel isothiazolo [4,3-b]pyridines
GB201314961D0 (en) Spirocyclic derivatives
GB201314965D0 (en) Spirocyclic derivatives

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed